Physics-Powered GenAI Biotech Gero Raises $6M to Find Root Causes of Aging and Age-Related Diseases

PALO ALTO, Calif.–(BUSINESS WIRE)–Gero, a biotechnology company focused on aging and chronic diseases, has closed a $6M Series A extension round.
Click here to view original post